177 related articles for article (PubMed ID: 38037067)
1. Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
Ling Q; Huang ST; Yu TH; Liu HL; Zhao LY; Chen XL; Liu K; Chen XZ; Yang K; Hu JK; Zhang WH
World J Surg Oncol; 2023 Dec; 21(1):377. PubMed ID: 38037067
[TBL] [Abstract][Full Text] [Related]
2. Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis.
Zhai Y; Zheng Z; Deng W; Yin J; Bai Z; Liu X; Zhang J; Zhang Z
Front Surg; 2022; 9():1047456. PubMed ID: 36726960
[TBL] [Abstract][Full Text] [Related]
3. Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.
Liu Z; Zhang Z; Liu H; Chen J
Future Oncol; 2023 Feb; 19(5):397-408. PubMed ID: 36919890
[No Abstract] [Full Text] [Related]
4. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
8. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.
Coleridge SL; Bryant A; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210
[TBL] [Abstract][Full Text] [Related]
10. Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis.
Naveed S; Banday SZ; Qari H; Zahoor S; Batoo AJ; Wahid MA; Haq MFU
Euroasian J Hepatogastroenterol; 2022; 12(2):81-91. PubMed ID: 36959991
[TBL] [Abstract][Full Text] [Related]
11. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
12. Long-Term Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer/Esophagogastric Junction Cancer: A Systematic Review and Meta-Analysis.
Wu F; Hong J; Du N; Wang Y; Chen J; He Y; Chen P
Anticancer Agents Med Chem; 2022; 22(1):143-151. PubMed ID: 33719964
[TBL] [Abstract][Full Text] [Related]
13. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.
Kumar S; Shelley M; Harrison C; Coles B; Wilt TJ; Mason MD
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006019. PubMed ID: 17054269
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.
Anderson E; LeVee A; Kim S; Atkins K; Guan M; Placencio-Hickok V; Moshayedi N; Hendifar A; Osipov A; Gangi A; Burch M; Waters K; Cho M; Klempner S; Chao J; Kamrava M; Gong J
JAMA Netw Open; 2021 Dec; 4(12):e2138432. PubMed ID: 34889947
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for advanced gastric cancer.
Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
[TBL] [Abstract][Full Text] [Related]
16. Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis.
Wei C; Du X; Hu J; Dong Y; Chen Y; Cao B
Crit Rev Oncol Hematol; 2024 Jun; 198():104082. PubMed ID: 37532103
[TBL] [Abstract][Full Text] [Related]
17. Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival.
Coada CA; Dondi G; Ravegnini G; Di Costanzo S; Tesei M; Fiuzzi E; Di Stanislao M; Giunchi S; Zamagni C; Bovicelli A; Hrelia P; Angelini S; De Iaco P; Perrone AM
J Gynecol Oncol; 2023 Nov; 34(6):e82. PubMed ID: 37743060
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of perioperative and long-term outcomes of laparoscopic versus open gastrectomy for advanced gastric cancer after neoadjuvant therapy: an updated pooled analysis of eighteen studies.
Pang HY; Chen XF; Chen LH; Yan MH; Chen ZX; Sun H
Eur J Med Res; 2023 Jul; 28(1):224. PubMed ID: 37408041
[TBL] [Abstract][Full Text] [Related]
19. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.
Omarini C; Guaitoli G; Noventa S; Andreotti A; Gambini A; Palma E; Papi S; Tazzioli G; Balduzzi S; Dominici M; Cascinu S; Piacentini F
Eur J Surg Oncol; 2017 Apr; 43(4):613-618. PubMed ID: 27793416
[TBL] [Abstract][Full Text] [Related]
20. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
Miao ZF; Liu XY; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Xu H; Xu HM
BMC Cancer; 2018 Jan; 18(1):118. PubMed ID: 29385994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
